Advanced Enzymes Technologies Limited’s (AETL) board of directors have approved the issuance of 4,92,630 equity shares of SciTech Specialities Private Limited (SSPL) to be offered on a preferential issue/private placement basis by SSPL. It also includes the purchase of 27,778 equity shares from selling shareholders of SSPL, aggregating to 5,20,408 equity shares i.e. 51 per cent of the equity share capital of SSPL.